Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lo Coco, F
Right arrow Articles by Dalla-Favera, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lo Coco, F
Right arrow Articles by Dalla-Favera, R
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma

F Lo Coco, BH Ye, F Lista, P Corradini, K Offit, DM Knowles, RS Chaganti and R Dalla-Favera

Department of Pathology, College of Physicians & Surgeons, Columbia University, New York, NY 10032.

The pathogenesis of non-Hodgkin's lymphoma (NHL) with a large cell component (DLLC, including diffuse large cell, DLCL; diffuse mixed cell, MX-D; and immunoblastic, IMB) is unknown. A novel candidate proto- oncogene, BCL6, that is involved in chromosome band 3q27 aberrations in NHL has been recently identified. We have investigated the incidence and disease-specificity of BCL6 rearrangements in a large panel of lymphoid tumors, including acute and chronic lymphoid leukemias (96 cases), various NHL types (125 cases), and multiple myelomas (23 cases). BCL6 rearrangements were found in 16/45 (35.5%) DLLC, more frequently in DLCL (15/33, 45%) than in MX-D (1/10, 10%), in 2/31 (6.4%) follicular NHL, and in no other tumor types. BCL6 rearrangements represent the first genetic lesion specifically and recurrently associated with DLLC and should prove useful for understanding the pathogenesis as well as for the clinical monitoring of these tumors.

Volume 83, Issue 7, pp. 1757-1759, 04/01/1994
Copyright © 1994 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JCOHome page
F. M. Cady, B. P. O'Neill, M. E. Law, P. A. Decker, D. M. Kurtz, C. Giannini, A. B. Porter, P. J. Kurtin, P. B. Johnston, A. Dogan, et al.
Del(6)(q22) and BCL6 Rearrangements in Primary CNS Lymphoma Are Indicators of an Aggressive Clinical Course
J. Clin. Oncol., October 10, 2008; 26(29): 4814 - 4819.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S. Prakash and S. H Swerdlow
Nodal aggressive B-cell lymphomas: a diagnostic approach
J. Clin. Pathol., October 1, 2007; 60(10): 1076 - 1085.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y.-W. Chen, X.-T. Hu, A. C. Liang, W.-Y. Au, C.-C. So, M. L. Wong, L. Shen, Q. Tao, K.-M. Chu, Y.-L. Kwong, et al.
High BCL6 expression predicts better prognosis, independent of BCL6 translocation status, translocation partner, or BCL6-deregulating mutations, in gastric lymphoma
Blood, October 1, 2006; 108(7): 2373 - 2383.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D. J. Wallace, D. Shen, G. F. Reed, M. Miyanaga, M. Mochizuki, H. N. Sen, S. S. Dahr, R. R. Buggage, R. B. Nussenblatt, and C.-C. Chan
Detection of the bcl-2 t(14;18) Translocation and Proto-Oncogene Expression in Primary Intraocular Lymphoma.
Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 2750 - 2756.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
I. S. Lossos
Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma
J. Clin. Oncol., September 10, 2005; 23(26): 6351 - 6357.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
O. A. O'Connor
Targeting Histones and Proteasomes: New Strategies for the Treatment of Lymphoma
J. Clin. Oncol., September 10, 2005; 23(26): 6429 - 6436.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. B. Harris, J. Mostecki, and P. B. Rothman
Repression of an Interleukin-4-responsive Promoter Requires Cooperative BCL-6 Function
J. Biol. Chem., April 1, 2005; 280(13): 13114 - 13121.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. Piazza, J. A. Costoya, T. Merghoub, R. M. Hobbs, and P. P. Pandolfi
Disruption of PLZP in Mice Leads to Increased T-Lymphocyte Proliferation, Cytokine Production, and Altered Hematopoietic Stem Cell Homeostasis
Mol. Cell. Biol., December 1, 2004; 24(23): 10456 - 10469.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Rivailler, A. Carville, A. Kaur, P. Rao, C. Quink, J. L. Kutok, S. Westmoreland, S. Klumpp, M. Simon, J. C. Aster, et al.
Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host
Blood, September 1, 2004; 104(5): 1482 - 1489.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. Katzenberger, G. Ott, T. Klein, J. Kalla, H. K. Muller-Hermelink, and M. M. Ott
Cytogenetic Alterations Affecting BCL6 Are Predominantly Found in Follicular Lymphomas Grade 3B with a Diffuse Large B-Cell Component
Am. J. Pathol., August 1, 2004; 165(2): 481 - 490.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
E. Smith and M. Sigvardsson
The roles of transcription factors in B lymphocyte commitment, development, and transformation
J. Leukoc. Biol., June 1, 2004; 75(6): 973 - 981.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Akasaka, I. S. Lossos, and R. Levy
BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma
Blood, August 15, 2003; 102(4): 1443 - 1448.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H. Niu, G. Cattoretti, and R. Dalla-Favera
BCL6 Controls the Expression of the B7-1/CD80 Costimulatory Receptor in Germinal Center B Cells
J. Exp. Med., July 21, 2003; 198(2): 211 - 221.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Pasqualucci, A. Migliazza, K. Basso, J. Houldsworth, R. S. K. Chaganti, and R. Dalla-Favera
Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma
Blood, April 15, 2003; 101(8): 2914 - 2923.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Sanchez-Beato, A. Sanchez-Aguilera, and M. A. Piris
Cell cycle deregulation in B-cell lymphomas
Blood, February 15, 2003; 101(4): 1220 - 1235.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. Wlodarska, P. Nooyen, B. Maes, J. I. Martin-Subero, R. Siebert, P. Pauwels, C. De Wolf-Peeters, and A. Hagemeijer
Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma
Blood, January 15, 2003; 101(2): 706 - 710.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. P. Butler, S. Iida, D. Capello, D. Rossi, P. H. Rao, P. Nallasivam, D. C. Louie, S. Chaganti, T. Au, R. D. Gascoyne, et al.
Alternative Translocation Breakpoint Cluster Region 5' to BCL-6 in B-cell Non-Hodgkin's Lymphoma
Cancer Res., July 15, 2002; 62(14): 4089 - 4094.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. J. Biagi and J. F. Seymour
Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation
Blood, May 29, 2002; 99(12): 4265 - 4275.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Melnick, G. Carlile, K. F. Ahmad, C.-L. Kiang, C. Corcoran, V. Bardwell, G. G. Prive, and J. D. Licht
Critical Residues within the BTB Domain of PLZF and Bcl-6 Modulate Interaction with Corepressors
Mol. Cell. Biol., March 15, 2002; 22(6): 1804 - 1818.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Falini and D. Y. Mason
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry
Blood, January 15, 2002; 99(2): 409 - 426.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
G. Steele-Perkins, W. Fang, X.-H. Yang, M. Van Gele, T. Carling, J. Gu, I. M. Buyse, J. A. Fletcher, J. Liu, R. Bronson, et al.
Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily
Genes & Dev., September 1, 2001; 15(17): 2250 - 2262.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. S. Lossos, C. D. Jones, R. Warnke, Y. Natkunam, H. Kaizer, J. L. Zehnder, R. Tibshirani, and R. Levy
Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma
Blood, August 15, 2001; 98(4): 945 - 951.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. Seitz, M. Hummel, I. Anagnostopoulos, and H. Stein
Analysis of BCL-6 mutations in classic Hodgkin disease of the B- and T-cell type
Blood, April 15, 2001; 97(8): 2401 - 2405.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Migliazza, F. Bosch, H. Komatsu, E. Cayanis, S. Martinotti, E. Toniato, E. Guccione, X. Qu, M. Chien, V. V. V. Murty, et al.
Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia
Blood, April 1, 2001; 97(7): 2098 - 2104.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Hyjek, A. Chadburn, Y. F. Liu, E. Cesarman, and D. M. Knowles
BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus
Blood, January 1, 2001; 97(1): 270 - 276.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
D. A. Arber
Molecular Diagnostic Approach to Non-Hodgkin's Lymphoma
J. Mol. Diagn., November 1, 2000; 2(4): 178 - 190.
[Full Text]


Home page
Genes Dev.Home page
K. D. Huynh, W. Fischle, E. Verdin, and V. J. Bardwell
BCoR, a novel corepressor involved in BCL-6 repression
Genes & Dev., July 15, 2000; 14(14): 1810 - 1823.
[Abstract] [Full Text]


Home page
BloodHome page
I. S. Lossos and R. Levy
Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5' noncoding regulatory region of the BCL-6 gene
Blood, July 15, 2000; 96(2): 635 - 639.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Hosokawa, Y. Maeda, R. Ichinohasama, I. Miura, M. Taniwaki, and M. Seto
The Ikaros gene, a central regulator of lymphoid differentiation, fuses to the BCL6 gene as a result of t(3;7)(q27;p12) translocation in a patient with diffuse large B-cell lymphoma
Blood, April 15, 2000; 95(8): 2719 - 2721.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Starostik, A. Greiner, A. Schultz, A. Zettl, K. Peters, A. Rosenwald, M. Kolve, and H. K. Muller-Hermelink
Genetic aberrations common in gastric high-grade large B-cell lymphoma
Blood, February 15, 2000; 95(4): 1180 - 1187.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. S. Lossos and R. Levy
Mutation analysis of the 5' noncoding regulatory region of the BCL-6 gene in non-Hodgkin lymphoma: evidence for recurrent mutations and intraclonal heterogeneity
Blood, February 15, 2000; 95(4): 1400 - 1405.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Capello, U. Vitolo, L. Pasqualucci, S. Quattrone, G. Migliaretti, L. Fassone, C. Ariatti, D. Vivenza, A. Gloghini, C. Pastore, et al.
Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia
Blood, January 15, 2000; 95(2): 651 - 659.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. B. Harris, C.-C. Chang, M. T. Berton, N. N. Danial, J. Zhang, D. Kuehner, B. H. Ye, M. Kvatyuk, P. P. Pandolfi, G. Cattoretti, et al.
Transcriptional Repression of Stat6-Dependent Interleukin-4-Induced Genes by BCL-6: Specific Regulation of Ivarepsilon Transcription and Immunoglobulin E Switching
Mol. Cell. Biol., October 1, 1999; 19(10): 7264 - 7275.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Yoshida, T. Fukuda, M. Hatano, H. Koseki, S.-i. Okabe, K. Ishibashi, S. Kojima, M. Arima, I. Komuro, G. Ishii, et al.
The role of Bcl6 in mature cardiac myocytes
Cardiovasc Res, June 1, 1999; 42(3): 670 - 679.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
A. ALIZADEH, M. EISEN, R.E. DAVIS, C. MA, H. SABET, T. TRAN, J. I. POWELL, L. YANG, G.E. MARTI, D. T. MOORE, et al.
The Lymphochip: A Specialized cDNA Microarray for the Genomic-scale Analysis of Gene Expression in Normal and Malignant Lymphocytes
Cold Spring Harb Symp Quant Biol, January 1, 1999; 64(0): 71 - 78.
[Abstract] [PDF]


Home page
BloodHome page
M.H.H. Kramer, J. Hermans, E. Wijburg, K. Philippo, E. Geelen, J.H.J.M. van Krieken, D. de Jong, E. Maartense, E. Schuuring, and P.M. Kluin
Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma
Blood, November 1, 1998; 92(9): 3152 - 3162.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Cesarman, A. Chadburn, Y.-F. Liu, A. Migliazza, R. Dalla-Favera, and D. M. Knowles
BCL-6 Gene Mutations in Posttransplantation Lymphoproliferative Disorders Predict Response to Therapy and Clinical Outcome
Blood, October 1, 1998; 92(7): 2294 - 2302.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. M. Larocca, D. Capello, A. Rinelli, S. Nori, A. Antinori, A. Gloghini, A. Cingolani, A. Migliazza, G. Saglio, S. Cammilleri-Broet, et al.
The Molecular and Phenotypic Profile of Primary Central Nervous System Lymphoma Identifies Distinct Categories of the Disease and Is Consistent With Histogenetic Derivation From Germinal Center-Related B Cells
Blood, August 1, 1998; 92(3): 1011 - 1019.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
H. Niu, B. H. Ye, and R. Dalla-Favera
Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor
Genes & Dev., July 1, 1998; 12(13): 1953 - 1961.
[Abstract] [Full Text]


Home page
The OncologistHome page
C. Nicolaides, S. Dimou, and N. Pavlidis
Prognostic Factors in Aggressive Non-Hodgkin's Lymphomas
Oncologist, June 1, 1998; 3(3): 189 - 197.
[Abstract] [Full Text]


Home page
J Natl Cancer Inst MonogrHome page
G. Gaidano, A. Carbone, and R. Dalla-Favera
Genetic Basis of Acquired Immunodeficiency Syndrome-Related Lymphomagenesis
J Natl Cancer Inst Monographs, April 1, 1998; 1998(23): 95 - 100.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Dhordain, O. Albagli, R. J. Lin, S. Ansieau, S. Quief, A. Leutz, J.-P. Kerckaert, R. M. Evans, and D. Leprince
Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein
PNAS, September 30, 1997; 94(20): 10762 - 10767.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
T. Fukuda, T. Yoshida, S. Okada, M. Hatano, T. Miki, K. Ishibashi, S. Okabe, H. Koseki, S. Hirosawa, M. Taniguchi, et al.
Disruption of the Bcl6 Gene Results in an Impaired Germinal Center Formation
J. Exp. Med., August 4, 1997; 186(3): 439 - 448.
[Abstract]